NZX company comparison

Compare NZX companies side by side

Select two or three covered companies to compare their latest source-backed financial metrics, reporting periods, and analytical context.

Rua Bioscience (RUA)BLIS Technologies (BLT)Summerset Group Holdings (SUM)

Showing 3 companies.

← Swipe to view more

Company comparison table
Metric	RUA · FY26	BLT · FY26	SUM · HY26
Revenue	$2.9m	$14.7m	$200.3m
Revenue growth %	93.5%	16.0%Outside range high revenue growth. 16%; 3-period range 9.7% to 14.2%. Revenue growth: 16.0%, above normal range; 3-period mean 12.2%, range 9.7%-14.2%.	15.7%
Operating profit	-$3m	—	$140.5m
Operating profit margin %	-104.3%	—	70.2%
PBT	-$3.4m	$0.8m	$179.1m
PBT growth %	—	-11.1%	63.1%Outside range high pbt growth. 63.1%; 3-period range -9.1% to -5%. PBT growth: 63.1%, above normal range; 3-period mean -6.6%, range -9.1%--5.0%.
NPAT	-$3.4m	$0.7m	$171.4m
NPAT growth %	—	-12.5%	34.7%Outside range high npat growth. 34.7%; 3-period range -23.2% to 24.5%. NPAT growth: 34.7%, above normal range; 3-period mean 0.1%, range -23.2%-24.5%.
Operating cash flow	-$3m	-$0.6m	$279.9m
OCF / Operating profit %	97.1%	—	199.2%
FCF pre-lease	-$3m	-$1.1m	$227.2m
FCF post-lease	—	—	-$54.4m
DPS	—	—	3.8c
Payout ratio vs NPAT %	—	—	5.4%Outside range low payout ratio versus npat. 5.4%; 3-period range 19.7% to 26%. Payout ratio versus NPAT: 5.4%, below normal range; 3-period mean 22.3%, range 19.7%-26.0%.

Source: latest published result for each selected company.

RUA vs BLT vs SUM comparison

Copy, export, or share this public comparison table.

Get new briefings that refresh this comparison when covered companies publish.